Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle.
DOI:
https://doi.org/10.26641/2307-0404.2020.2.206368Ключевые слова:
permanent atrial fibrillation, chronic heart failure with mid-range ejection fraction, clinical course, prognosisАннотация
The purpose of the study was to establish clinical features of permanent atrial fibrillation (AF) in patients with heart failure mid-range ejection fraction (HFmrEF) and to develop a mathematical model for predicting arrhythmia development. The study included 42 patients with IHD, arterial hypertension (AH), permanent AF and HFmrEF (1 group), mean age – 68.0±1.2 years (21 men and 21 women) and 36 patients with CAD / АH and HFmrEF without AF, mean age- 67.5±0.7 years (22 men and 14 women). The results of the study show, that patients with permanent AF and HFmrEF are characterized by the higher diastolic arterial pressure, higher values of the LDLP, iESV LV, index of end-systolic volume of LV septal thickness and lower EF of the LV in comparison with patients without AF. Patients with permanent AF and HFmrEF also have increased plasma levels of hsCRP, IL-1β, IL-6 and IL-10 in comparison with patients without AF. A mathematical model with scoring system of hsCRP, IL-1β, LV mass index, HDLP, LDLP was developed to assess the risk of AF development in patients with HFmrEF with accuracy of 85.9%, sensitivity of 85.7% and specificity of 86.1%.
Библиографические ссылки
Bubeshko DA, Snezhitskiy VA, Shulika VR. [Biomarkers of inflammation in patients with nonvalvular atrial fibrillation and left ventricular systolic dysfunction]. Med. news. 2017;4:69-72.
Voronkov LG, Ilnytska MR, Babich PM. [The prognosis of patient with chronic heart failure and left ventricular systolic depending on the data noninvasive method examination]. Ukr. therap. j. 2010;2:33-39.
Odutayo A, Wong CX, Hsiao AJ, et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. Bmj. 2016;354:448-54. doi: https://doi.org/10.3389/fneur.2017.00668
Startipy U, Dahlström U, Fu M, et. al. Atrial Fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC: heart failure. 2017;5(8):565-74. doi: https://doi.org/10.1016/j.jchf.2017.05.001
Schnabel R, Pecen L, Engler D, et al. Atrial fibrillation patterns are associated with arrhythmia progression and clinical. Heart. 2018;34(5):24-36. doi: https://doi.org/10.1136/heartjnl-2017-312569
Batul SA, Gopinathannair R. Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ. J. 2017;47(5):644-62. doi: https://doi.org/10.4070/kcj.2017.0040
McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur. Heart J. 2012;33:1787-847. doi: https://doi.org/10.1093/eurheartj/ehs104
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Euro. Heart J. 2016;37(27):2129–200. doi: https://doi.org/10.1093/eurheartj/ehw128
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Euro. Heart J. 2016;37(38):2893-962. doi: https://doi.org/10.5603/KP.2016.0172
Global Burden of Disease Collaborative Network (2016) Global Burden of Disease Study 2016 (GBD 2016) Results. Institute for Health Metrics and Evaluation (IHME). Seattle, United States; 2017. Available from: http://ghdx.healthdata.org/gbd-results-tool
Mitchell C, Rahko PS, Blauwet LA, et. al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography 2019. J. of the Am. Soc. of Echocard. 2019;32(1):1-64. doi: https://doi.org/10.1016/j.echo.2018.06.004
Yang Song NEI, Cannon CP, Doros G, et. al. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®. 2019;6(4):784-92. doi: https://doi.org/10.1002/ehf2.12455
Ballatore A, Matta M, Saglietto A, et. al. Subclinical and Asymptomatic Atrial Fibrillation: Current Evidence and Unsolved Questions in Clinical Practice. Medicina. 2019;55(8):497. doi: https://doi.org/10.3390/medicina55080497
Verma JM, Kalman. DJ. Callans. Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction. Circulation. 2017;136(16):1547-63. doi: https://doi.org/10.1161/CIRCULATIONAHA.116.026054
Загрузки
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2020 Medicni perspektivi (Medical perspectives)
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
